MedPath

Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects

Not Applicable
Completed
Conditions
Catastrophization
Interventions
Other: Cognitive Therapy
Other: Routine Care
Registration Number
NCT01772329
Lead Sponsor
Rush University Medical Center
Brief Summary

The investigators propose a randomized controlled trial to evaluate the effects of treatment intended to reduce pain catastrophizing among patients reporting high pain catastrophizing prior to total knee replacement(TKR), total hip replacement(THR), or shoulder surgery in an effort to thereby reduce the incidence of persistent post-surgical pain (PPP) and enhance physical function at 3-months post-surgery. Preemptive treatment aimed at a known predictor of PPP following total knee replacement is highly innovative and have potentially high impact for public health. Cognitive therapy is a well-tolerated modality among chronic pain patients with few if any side effects. Cognitive therapy (CT) represents an inexpensive method that could greatly reduce suffering and costly post-surgical pain management for high risk TKR patients.

Detailed Description

Aim 1 is to determine which CT protocol is most effective in reducing Pain Catastrophizing Scale (PCS) and Coping Strategies Questionnaire Catastrophizing Subscale (CSQ-CAT) scores in high-risk TKR candidates. CT will consist of four-to-eight weekly 1-hr individual cognitive therapy sessions prior to surgery.

Aim 2 is to compare the most efficient treatment from Aim 1 with a control group to evaluate pain relief at 3 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  1. undergoing standard primary TKR; THR or Shoulder Surgery
  2. 18- 85 yrs of age;
  3. Surgical joint is the primary source of patient's pain;
  4. Patient agrees to preoperative visits and treatment, follow-up visits and treatment, and to comply with the assessment tests;
  5. Patient consents to standard anesthetic and analgesic protocol, with medical care as deemed necessary by the anesthesiologist, and has no contraindications.
  6. Patient has been diagnosed with osteoarthritis.
Exclusion Criteria
  1. Currently using antidepressant medication or undergoing cognitive therapy;
  2. chronic opioid use ≥ 10 mg/day of morphine equivalents within one wk prior to the surgery, and duration of use > 4 wks;
  3. history of opioid abuse;
  4. inability to understand and communicate with the investigators to complete the study related questionnaires
  5. patient is planning to undergo another elective joint procedure during the 6-mo period of participation;
  6. any co-morbidity which results in severe systemic disease limiting function {as defined by the American Society of Anesthesiology (ASA) physical status classification > 3}.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
4 weekly CT sessions - Tele-videoCognitive Therapy4 weekly CT sessions; 1st and 4th will be 1-hr individual cognitive therapy session with the psychology staff. The intermediate CT sessions will be by telephone call or video/"Skype".
Routine careRoutine CareRoutine care; no CT sessions
4 weekly CT sessions - in personCognitive Therapy4 weekly CT sessions; all will be 1-hr individual cognitive therapy sessions with the psychology staff (under the supervision of John Burns, PhD).
8 weekly CT sessionsCognitive Therapy8 weekly CT sessions; 1st and 8th will be 1-hr individual cognitive therapy session with the psychology staff (under the supervision of John Burns, PhD). The intermediate CT sessions will be by telephone call or video/"Skype". Our group will purchase and setup a web camera and headphone/microphone for the subjects in the CT groups that use "Skype". The 1-hr CT protocol was adapted from Dr. Beverly E. Thorn's CT manual (Cognitive Therapy for Chronic Pain: A Step-by-Step Guide; Thorn, 2004; with the Client and Therapy Workbooks.
Primary Outcome Measures
NameTimeMethod
(Aim 1) Pain Catastrophizing Scale (PCS)4 or 8 weeks after start of treatment

Pain Catastrophizing Scale - Min=0, Max=52, Higher score = more catastrophizing so lower scores are preferable.

(Aim 2) Proportion of patients with pain relief3 month

Proportion of patients w a 3 month decrease in WOMAC pain subscale \<= 4. (WOMAC Osteoarthritis Index)

Secondary Outcome Measures
NameTimeMethod
Patient Health Questionnaire (PHQ-8)4 and 8 weeks after start of treatment

Patient Health Questionnaire (PHQ-8): The eight-item Patient Health Questionnaire depression scale (PHQ-8) is established as a valid diagnostic and severity measure for depressive disorders

Generalized anxiety disorder (GAD-7)4 and 8 weeks after start of treatment

Generalized anxiety disorder (GAD-7): The seven-item Generalized Anxiety Disorder Scale (GAD-7) is a practical self-report anxiety questionnaire.

Trial Locations

Locations (1)

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath